Cup and handle pattern + rising triangle on daily
✨️ EIPICO Pharmaceuticals (PHAR)
The stock has formed a cup and handle pattern on the weekly chart. On the daily chart, a rising triangle has also been confirmed, with today’s breakout above both patterns supported by the highest trading volume in the past 8 months.
If the stock manages to hold above 54, it will be positioned for the following targets:
Short-term: 60
Medium to long-term: 74 – 80 (targets of both chart patterns)
⚠️ Currently, the 54 level serves as the stop-loss. In case of a close below it, stop-loss should be activated to protect capital.
Trading Plan:
Stock Code: PHAR
Potential Buy Range: 54 – 55.7
TP1: 60
TP2: 74
TP3: 80
Stop-Loss: 54 (confirmation required)
Trailing stop-loss is recommended
The stock has formed a cup and handle pattern on the weekly chart. On the daily chart, a rising triangle has also been confirmed, with today’s breakout above both patterns supported by the highest trading volume in the past 8 months.
If the stock manages to hold above 54, it will be positioned for the following targets:
Short-term: 60
Medium to long-term: 74 – 80 (targets of both chart patterns)
⚠️ Currently, the 54 level serves as the stop-loss. In case of a close below it, stop-loss should be activated to protect capital.
Trading Plan:
Stock Code: PHAR
Potential Buy Range: 54 – 55.7
TP1: 60
TP2: 74
TP3: 80
Stop-Loss: 54 (confirmation required)
Trailing stop-loss is recommended
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.